Keywords:
Keywords:
Le nouvel anticorps monoclonal ligelizumab n'a montré aucune amélioration en phase 3...
ByCAMEROON MAGAZINE - GM20/12/2021La Commission européenne (CE) a approuvé le Cibinqo (abrocitinib) de Pfizer pour...
ByCAMEROON MAGAZINE - GM14/12/2021The skin infection in question is caused by the bacterium Mycobacterium ulcerans...
ByCAMEROON MAGAZINE - GM24/02/2021Ref: https://www.9news.com.au
ByCAMEROON MAGAZINE - GM23/02/2021